SHALBY.NS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 11:59):

Stats
Dagens volum	100 521
Gjennomsnittsvolum	273 708
Markedsverdi	30.11B
EPS	INR0 ( 2024-02-12 )
Neste inntjeningsdato	( INR0 ) 2024-05-12
Last Dividend	INR1.200 ( 2023-08-08 )
Next Dividend	INR0 ( N/A )
P/E	36.78
ATR14	INR0.332 (0.12%)

Volum Korrelasjon

Lang: -0.12 (neutral)

Kort: 0.34 (neutral)

Signal:(36.291) Neutral

Shalby Limited Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Shalby Limited Korrelasjon - Valuta/Råvare

-0.37
( neutral )

0.18
( neutral )

-0.42
( neutral )

0.42
( neutral )

0.45
( neutral )

0.13
( neutral )

Shalby Limited Økonomi

Annual	2022
Omsetning:	INR8.05B
Bruttogevinst:	INR3.70B (45.94 %)
EPS:	INR6.30

FY	2022
Omsetning:	INR8.05B
Bruttogevinst:	INR3.70B (45.94 %)
EPS:	INR6.30

FY	2022
Omsetning:	INR6.99B
Bruttogevinst:	INR3.05B (43.58 %)
EPS:	INR6.46

FY	2021
Omsetning:	INR4.31B
Bruttogevinst:	INR1.81B (42.07 %)
EPS:	INR4.71

Financial Reports:

No articles found.

Shalby Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR1.000 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR1.200 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Shalby Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.43 - low (14.10%) | Divividend Growth Potential Score: 4.23 - Stable (15.48%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.500	2019-08-16
Last Dividend	INR1.200	2023-08-08
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	5	--
Total Paid Out	INR4.20	--
Avg. Dividend % Per Year	0.51%	--
Score	1.9	--
Div. Sustainability Score	3.43
Div.Growth Potential Score	4.23
Div. Directional Score	3.83	--

Next Divdend (Est)
(2024-07-01)

INR1.377 Estimate 3.09 %

Dividend Stability

0.25 Very Poor

Dividend Score

1.90

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2019	INR0.500	0.34%
2020	INR0.500	0.54%
2021	INR1.000	0.92%
2022	INR1.000	0.70%
2023	INR1.200	0.79%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SSWL.NS	Dividend Junior	2023-08-14	Annually	20	0.30%
MSUMI.NS	Dividend Junior	2023-08-09	Annually	3	0.60%
HIKAL.NS	Dividend Junior	2023-09-18	Semi-Annually	23	0.37%
BLUEDART.NS	Dividend Junior	2023-07-19	Annually	22	0.45%
REDINGTON.NS	Dividend Knight	2023-07-06	Annually	18	3.28%
KPITTECH.NS	Dividend Knight	2023-08-14	Annually	6	0.47%
FACT.NS	Dividend Junior	2023-09-22	Insufficient data to determine frequency	2	0.09%
AMRUTANJAN.NS	Dividend Knight	2023-09-14	Semi-Annually	15	0.38%
TASTYBITE.NS	Dividend Junior	2023-07-14	Annually	8	0.01%
NH.NS	Dividend Junior	2023-07-06	Sporadic	6	0.14%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0916	1.500	8.17	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.0860	1.500	-0.155	-0.233	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	10.77	1.000	7.12	7.12	[3 - 30]
operatingCashFlowPerShareTTM	6.92	2.00	7.69	10.00	[0 - 30]
freeCashFlowPerShareTTM	6.92	2.00	6.54	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.464	1.000	5.60	5.60	[0.2 - 0.8]
operatingProfitMarginTTM	0.150	1.000	9.00	9.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.43

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	36.94	1.000	6.37	0	[1 - 100]
returnOnEquityTTM	0.0860	2.50	-0.0997	-0.233	[0.1 - 1.5]
freeCashFlowPerShareTTM	6.92	2.00	7.69	10.00	[0 - 30]
dividendYielPercentageTTM	0.428	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	6.92	2.00	7.69	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	1.344	1.500	4.37	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0834	1.000	-0.415	0	[0.1 - 0.5]
Total Score				4.23

Shalby Limited

Shalby Limited operates multi-specialty hospitals primarily in India. The company offers arthroscopy, arthroplasty, cardiology, cardiothoracic and vascular surgery, cosmetic and aesthetic, dental cosmetic and implant ology, emergency medicine, endocrinology, endoscopy and laparoscopy, ENT surgery, gastroentero surgery, gastroenterology, general medicine and surgery, hair transplant, liver disease and transplant, and hip and knee joint replacement services. It also provides infectious disease, infertility and IVF, intensive and critical care, maxillofacial surgery, nephrology, neuro surgery, neurology, obesity surgery, obstetrics and gynecology, oncology, oncosurgery, ophthalmology and glaucoma, orthopedic and trauma, pediatric orthopedic, pathology and microbiology, pediatrics and neonatology, plastic surgery, pulmonology and chest, radiology and imaging, rheumatology, trauma, organ donation, and urosurgery services. The company operates 11 hospitals comprising aggregate capacity of 2,012 beds. In addition, it offers outpatient services through 50 outpatient clinics, as well as provides educational programs and fellowships for paramedical students and other healthcare professionals; and homecare health services, such as attendants, doctors, nursing, physiotherapy, pathology, pharmacy, and medical equipment, as well as conducts clinical research trials. It also operates in Kenya, Tanzania, Rwanda, Uganda, the United Arab Emirates, Bangladesh, Cambodia, Jakarta, Oman, Uzbekistan, Nepal, and internationally. The company was formerly known as Shalby Hospitals Limited and changed its name to Shalby Limited in February 2008. Shalby Limited was founded in 1994 and is headquartered in Ahmedabad, India.